For the first time, researchers from Helmholtz Zentrum München and the University Hospital of LMU Munich show that deep learning algorithms perform similar to human experts when classifying blood samples from patients suffering from acute myeloid leukemia (AML). Their proof of concept study ... more
Prof. Dr. Thomas Carell
Ludwig-Maximilians-Universität München (LMU), Department für Chemie
Thomas Carell graduated in chemistry, completing his doctorate at the Max Planck Institute for Medical Research under the tutelage of Prof. Dr Dr H. A. Staab. Following a research position in the USA, he accepted a position at ETH Zurich, setting up his own research group in the Laboratory for Organic Chemistry. After completing his habilitation in 1999, he moved to Philipps University Marburg, followed by LMU Munich in 2004. Prof. Carell is the director of Collaborative Research Centre 749 (Dynamic and Intermediate Molecular Transformations) and the CiPSM (Centre for Integrative Protein Science) excellence cluster. He is the holder of the Otto Bayer Prize, the German Research Foundation's Leibniz Prize and the Cross of the Order of Merit of the Federal Republic of Germany.